Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Accumulated Expenses (2011 - 2026)

Updated

Travere Therapeutics (TVTX) posted Accumulated Expenses of $136.27 million for Q2 2026, up 66.8% from $81.68 million a year earlier and up 30.5% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2025, Travere Therapeutics' Accumulated Expenses came in at $126.04 million, up 46.5% from FY2024.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
  • In prior years, Travere Therapeutics' Accumulated Expenses was $86.03 million in FY2024 (-27.7%), $118.99 million in FY2023 (+24.3%), $95.74 million in FY2022 (+27.4%) and $75.18 million in FY2021 (+32.4%).
  • The Q2 2026 figure stands as the highest quarterly Accumulated Expenses since Q1 2024.
  • On a year-over-year basis, Accumulated Expenses has increased in each of the last five quarters, with growth averaging 11.6% over the last eight quarters.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q2 2026, with growth of 66.8%; the weakest was Q1 2025, with a decline of 44.8%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $104.41 million (Q1 2026), $126.04 million (Q4 2025) and $105.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Travere Therapeutics 5.35 Bn 4.95 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136.27 Mn
Mar 31, 2026 104.41 Mn
Dec 31, 2025 126.04 Mn
Sep 30, 2025 105.76 Mn
Jun 30, 2025 81.68 Mn
Mar 31, 2025 77.11 Mn
Dec 31, 2024 86.03 Mn
Sep 30, 2024 83.92 Mn
Jun 30, 2024 79.64 Mn
Mar 31, 2024 139.58 Mn
Dec 31, 2023 118.99 Mn
Sep 30, 2023 95.71 Mn
Jun 30, 2023 88.75 Mn
Mar 31, 2023 85.77 Mn
Dec 31, 2022 95.74 Mn
Sep 30, 2022 88.38 Mn
Jun 30, 2022 82.69 Mn
Mar 31, 2022 69.24 Mn
Dec 31, 2021 75.18 Mn
Sep 30, 2021 63.31 Mn
API Access

Travere Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TVTX&period=max&api_key=YOUR_API_KEY